Imagion Biosystems President and CEO Bob Proulx was interviewed today by Health Professional Radio, a media network dedicated to promoting awareness on healthcare issues. In his interview of Mr. Proulx, Henry Acosta of Health Professional Radio draws out descriptions of the key elements of Imagion Biosystems’ MagSense® cancer detection technology, the company’s commercialization plan, and what motivates Mr. Proulx and the company’s employees, collaborators, and investors to get MagSense® technology into hospitals and medical clinics just as soon as possible.
Listen to the eight-minute audio file here:
Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
June 3, 2026
Imagion Biosystems, Ltd. (ASX: IBX) has announced that the US Food and Drug Administration (FDA) completed its review of the company’s investigational new drug (IND)